Figure 2.
Reduced LPP-CFC/HPP-CFC frequency and proliferation of p85α-/- and p85α-/-; p85β+/- c-kit+ fetal liver cells. c-kit+ cells were purified from WT, p85β+/-, p85α-/-, and p85α-/-p85β+/- fetal livers and plated in agar cultures containing growth factors that promote the growth of (A) LPP-CFCs and (B) HPP-CFCs. Data shown are the mean number of colonies per 4000 c-kit+ cells plated. *P < .05; n = 4. (C) Representative LPP-CFC photomicrographs generated from WT and p85α-/-; p85β+/- c-kit+ cells. Original magnification, × 40. (D) Proliferation of WT, p85β+/-, p85α-/-, and p85α-/-p85β+/- c-kit+ fetal liver cells in response to kitL. Freshly isolated c-kit+ fetal liver cells were plated in triplicate with no growth factors or 10 ng/mL KitL for 16 hours. Cells were pulsed with tritiated thymidine and harvested for measurement of β emission. Results represent the mean thymidine incorporation ± SEM of 9 independent experiments. *P < .05. (E) Akt activation of WT, p85β+/-, p85α-/-, and p85α-/-p85β+/- c-kit+ fetal liver cells in response to kitL. Western blots for Akt phosphorylation and total Akt are shown. Data are representative of 4 independent experiments. **P < .05 for p85α-/- vs p85α-/-p85β-/-.